|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Trade receivables | |||||||||
| Prepaid expenses and other receivables | |||||||||
| Inventory | |||||||||
| Total current assets | |||||||||
| NON-CURRENT ASSETS: | |||||||||
| Restricted cash | |||||||||
| Trade receivables | |||||||||
| Fixed assets | |||||||||
| Right-of-use assets | |||||||||
| Intangible assets | |||||||||
| Investment in a joint venture | |||||||||
| Total non-current assets | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES | |||||||||
| CURRENT LIABILITIES: | |||||||||
| Account payable | |||||||||
| Lease liabilities | |||||||||
| Allowance for deductions from revenue | |||||||||
| Derivative financial instruments | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Total current liabilities | |||||||||
| NON-CURRENT LIABILITIES: | |||||||||
| Lease liabilities | |||||||||
| Derivative financial instruments | |||||||||
| Accrued expenses and other non current liabilities | |||||||||
| Royalty obligation | |||||||||
| Total non-current liabilities | |||||||||
| TOTAL LIABILITIES | |||||||||
| EQUITY (CAPITAL DEFICIENCY): | |||||||||
| Ordinary shares | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| TOTAL EQUITY (CAPITAL DEFICIENCY) | |||||||||
| TOTAL LIABILITIES AND EQUITY (CAPITAL DEFICIENCY) | |||||||||
Loading...
